Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/24/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Tom Spitznagel

Wrong Dr. Tom Spitznagel?

Vice President, Development

Phone: (650) ***-****  HQ Phone
Email: s***@***.com
Local Address: Washington D.C., District of Columbia, United States
MacroGenics Inc
9640 Medical Center Drive
Rockville, Maryland 20850
United States

Company Description: Founded in 2000, MacroGenics is a private, fully-integrated biotechnology company headquartered in Rockville, Maryland that focuses on the development, manufacture...   more
Background

Employment History

Board Memberships and Affiliations

  • Scientific Advisory Board Member
    IBC Life Sciences

Education

  • BS , Chemical Engineering
    M.I.T
  • Ph.D. , Chemical Engineering
    University of California , Berkeley
  • Ph.D. , Chemical Engineering
    University of California at Berkeley
29 Total References
Web References
MANAGEMENT - HGS
www.hgsi.com, 23 Aug 2012 [cached]
Thomas M. Spitznagel, Ph.D.
Vice President, BioPharmaceutical Development
Thomas M. Spitznagel joined HGS in March 1998 as Group Leader, Formulation. Dr. Spitznagel has moved through a number of positions of increasing responsibility, including oversight of Analytical Development, Drug Delivery, Purification Sciences, Fermentation and Cell Culture Sciences, and Global Project Management. He was promoted to Vice President, BioPharmaceutical Development in May 2008. Prior to joining HGS, Dr. Spitznagel was a Senior Scientist at Nabi Biopharmaceuticals from 1996-1998, and a Staff Engineer at Genetics Institute from 1992-1996. During his tenure at Nabi, Dr. Spitznagel was responsible for scale-up and development of the purification process for polysaccharide-protein conjugate vaccines. During his tenure at Genetics Institute, Dr. Spitznagel was responsible for formulation and delivery system development for rhBMP-2, as well as finished product process development. Dr. Spitznagel earned his BS in Chemical Engineering at M.I.T, and his Ph.D. in Chemical Engineering at the University of California, Berkeley.
Formulation Strategies for Protein Therapeutics
www.ibclifesciences.com, 17 Sept 2010 [cached]
Thomas M. Spitznagel, Ph.D., Vice President, Biopharmaceutical Development, Human Genome Sciences, Inc.
Management - HGS
phx.corporate-ir.net, 23 Aug 2012 [cached]
Thomas M. Spitznagel, Ph.D. Vice President, BioPharmaceutical Development
Thomas M. Spitznagel joined HGS in March 1998 as Group Leader, Formulation. Dr. Spitznagel has moved through a number of positions of increasing responsibility, including oversight of Analytical Development, Drug Delivery, Purification Sciences, Fermentation and Cell Culture Sciences, and Global Project Management. He was promoted to Vice President, BioPharmaceutical Development in May 2008. Prior to joining HGS, Dr. Spitznagel was a Senior Scientist at Nabi Biopharmaceuticals from 1996-1998, and a Staff Engineer at Genetics Institute from 1992-1996. During his tenure at Nabi, Dr. Spitznagel was responsible for scale-up and development of the purification process for polysaccharide-protein conjugate vaccines. During his tenure at Genetics Institute, Dr. Spitznagel was responsible for formulation and delivery system development for rhBMP-2, as well as finished product process development. Dr. Spitznagel earned his BS in Chemical Engineering at M.I.T, and his Ph.D. in Chemical Engineering at the University of California, Berkeley.
Tom Spitznagel, Ph.D., Vice ...
www.chi-peptalk.com [cached]
Tom Spitznagel, Ph.D., Vice President, Development, MacroGenics, Inc
Dr. Spitznagel joined MacroGenics in 2013 as Vice President of Development. He has overall responsibility for both Biopharmaceutical Development and Manufacturing of MacroGenics' Fc-optimized mAbs and Dual-Affinity Re-Targeting (DART) antibody-like molecules. Prior to joining MacroGenics, he was Vice President, BioPharmaceutical Development at Human Genome Sciences. He joined HGS in March 1998 as Group Leader, Formulation. During his tenure, Dr. Spitznagel has had increasing levels of responsibility at HGS, including oversight of Analytical Development, Formulation and Drug Delivery, Purification Sciences, Fermentation and Cell Culture Sciences, and Global Project Management. Prior to joining HGS, Dr. Spitznagel was a Senior Scientist at Nabi from 1996-1998, and a Staff Engineer at Genetics Institute from 1992-1996. During his tenure at Nabi, Dr. Spitznagel was responsible for the scale-up and development of the purification process for polysaccharide-protein conjugate vaccines. During his tenure at Genetics Institute, Dr. Spitznagel was responsible for the formulation and delivery system development for rhBMP-2, as well as finished product process development.
Dr. Spitznagel earned his BS in Chemical Engineering at M.I.T, and his Ph.D. in Chemical Engineering at the University of California, Berkeley.
Optimizing Biologics Formulation Development - Day 1
www.chi-peptalk.com [cached]
Tom Spitznagel, Ph.D., Vice President, Development, MacroGenics, Inc.
Other People with the name "Spitznagel":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304